Treatment of the myelodysplastic syndromes: an updated Japanese experience.
Yoshida
Y
Y
Department of Medicine, Faculty of Medicine, Kyoto University, Japan.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002454:Cell Differentiation; D016207:Cytokines / Q000627:therapeutic use; D006133:Growth Substances / Q000627:therapeutic use; D006801:Humans; D007564:Japan; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*
D000970:Antineoplastic Agents; D016207:Cytokines; D006133:Growth Substances